Prostate cancer
Results
Phase 3
This trial was looking at a drug called zibotentan (ZD4054) for prostate cancer that had come back after hormone treatment. It was for men who had a rising PSA level but no signs that their cancer had spread to another area of the body.
Recruitment start: 15 January 2008
Recruitment end: 31 December 2010
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Heather Payne
AstraZeneca
Experimental Cancer Medicine Centre (ECMC)
Last reviewed: 11 Aug 2016
CRUK internal database number: 3970
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
